Development of Multimodal Fusion Warning System and Non-invasive Techniques for Early Alzheimer's Detection. - Trial NCT05978830
Access comprehensive clinical trial information for NCT05978830 through Pure Global AI's free database. This phase not specified trial is sponsored by First Affiliated Hospital of Zhejiang University and is currently Recruiting. The study focuses on Alzheimer's Disease. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
First Affiliated Hospital of Zhejiang University
Timeline & Enrollment
N/A
Mar 01, 2022
Dec 30, 2024
Primary Outcome
Power spectrum,Duration of microstate,Occurrence of microstate,Mini-Mental State Examination (MMSE),Montreal Cognitive Assessment (MoCA)
Summary
Developing and validating an early digitalized recognition device and multimodal warning
 model for Alzheimer's disease, and establishing a precision transcranial ultrasound
 stimulation intervention system.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05978830
Device Trial